MAP1B and infection: Western blot analysis revealed that the MAP1B protein levels were indeed higher in ASD patient neurons compared to those in human neurons differentiated from control human iPSCs (Ctrl1 and Ctrl3) and human ESCs (Ctrl4 and Ctrl5) and LV-shMAP1B infection reduced MAP1B levels in ASD neurons to levels similar to those in control neurons (Fig. 2d).